Zacks lowered shares of GenVec (NASDAQ:GNVC) to a neutral rating in a report released on Monday. Zacks currently has $2.00 price objective on the stock. GenVec, Inc. (NASDAQ:GNVC) belongs to Healthcare sector. Its weekly performance is -7.84%. On last trading day company shares ended up $1.88. GenVec, Inc. (NASDAQ:GNVC) distance from 50-day simple moving average (SMA50) is -1.95%.

-Magnetek, Inc. (NASDAQ: MAG), announced that its chief executive officer, Peter McCormick, and chief financial officer, Marty Schwenner, will present to institutional investors and analysts at the 10th annual Lambert, Edwards & Associates SMID-West Investor Conference, to be held on Dec. 4, 2014, at The Palmer House Hilton Hotel in Chicago. Magnetek Inc. (NASDAQ:MAG) shares fell -8.16% in last trading session and ended the day at $37.14. MAG Gross Margin is 35.30% and its return on assets is 8.30%. Magnetek Inc. (NASDAQ:MAG) quarterly performance is 17.57%.

MediWound Ltd. (NASDAQ:MDWD) announced that Company management participated at the Oppenheimer 25th Annual Healthcare Conference taking place from December 10-11 2014 in New York City. Gal Cohen President and Chief Executive Officer of MediWound will be presenting a corporate overview on Thursday December 11th at 3:20 p.m. Eastern time. On 10 December, MediWound Ltd. (NASDAQ:MDWD) shares fell -6.75% and was closed at $6.35. MDWD EPS growth in last 5 year was 0.00%. MediWound Ltd. (NASDAQ:MDWD) year to date (YTD) performance is -63.23%.

Clinical-stage biopharmaceutical company Kite Pharma, Inc. NASDAQ:KITE) On Wednesday priced its expanded follow-on public offering of 3.49 million shares of its common stock at $54 per share. Kite Pharma, Inc. (NASDAQ:KITE) belongs to Healthcare sector. Its weekly performance is 27.15%. On last trading day company shares ended up $54.37. Kite Pharma, Inc. (NASDAQ:KITE) distance from 50-day simple moving average (SMA50) is 42.12%.

On Dec. 4, TTM Technologies, Inc. (NASDAQ:TTMI) and Viasystems Group, Inc. announced that they have each received a second request from the United States Federal Trade Commission (the “FTC”) for additional information associated with TTM’s proposed acquisition of Viasystems. The request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”). TTM Technologies Inc. (NASDAQ:TTMI) shares fell -2.66% in last trading session and ended the day at $6.95. TTMI Gross Margin is 15.10% and its return on assets is 0.80%. TTM Technologies Inc. (NASDAQ:TTMI) quarterly performance is -7.09%.